Oncolytic Virus Immunotherapy Market Expected to Reach USD 572.2 million by 2031, Expanding at a 21.1% CAGR | Transparency Market Research, Inc. Wilmington, Delaware, United States, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global oncolytic virus immunotherapy market was projected to attain US$ 110.2 million...

Gene Vectors Market Predicted to Rise at a 12.6% CAGR until 2031, Reaching US$ 3.4 billion: TMR Report Wilmington, Delaware, United States, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - TMR predicted that the gene vector market is likely to reach US$ 3.4 billion by 2031. Gene...

Viral Vector Vaccines Market Size to Surpass US$ 1.23 billion by 2033 | Persistence Market Research New York, May 19, 2023 (GLOBE NEWSWIRE) -- The global viral vector vaccines market was valued at US$ 738.4 million in 2022 and is projected to expand at a CAGR of 3.9% over the forecast period (2023...

Viral Clearance and Viral Testing Services Global Market Report 2023: Rise of Biologics Bodes Well for Sector Dublin, Feb. 15, 2023 (GLOBE NEWSWIRE) -- The "Viral Clearance and Viral Testing Services Market - Distribution by Scale of Operation, Method of Viral Clearance and Testing, End-User and Key...

Advent Announces Corporate Name Change to Advaxia POMEZIA, Italy, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Advent announced today that it is changing its corporate name to Advaxia. The new name reflects the company's evolution, strategic growth and...